Found: 5
Select item for more details and to access through your institution.
Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 3, p. 882, doi. 10.1002/cam4.1903
- By:
- Publication type:
- Article
Prognostic Value of the Combination of Circulating Tumor Cells Plus KRAS in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 280, doi. 10.1016/j.clcc.2013.06.001
- By:
- Publication type:
- Article
Rechallenge with Anti-EGFR Treatment in RAS/BRAF wt Metastatic Colorectal Cancer (mCRC) in Real Clinical Practice: Experience of the GITuD Group.
- Published in:
- Targeted Oncology, 2024, v. 19, n. 4, p. 565, doi. 10.1007/s11523-024-01062-z
- By:
- Publication type:
- Article
Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol.
- Published in:
- BMC Cancer, 2010, v. 10, p. 528, doi. 10.1186/1471-2407-10-528
- By:
- Publication type:
- Article